CD4 c.44A>T ;(p.Q15L)

Variant ID: 12-6909348-A-T

NM_000616.4(CD4):c.44A>T;(p.Q15L)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.

Cancer Research
Dorta-Estremera, Stephanie S; Chin, Renee L RL; Sierra, Gloria G; Nicholas, Courtney C; Yanamandra, Ananta V AV; Nookala, Sita M K SMK; Yang, Guojun G; Singh, Shail S; Curran, Michael A MA; Sastry, K Jagannadha KJ
Publication Date: 2018-09-15

Variant appearance in text: CD4: Q15L
PubMed Link: 30054333
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Tan, Yee Sun YS; Sansanaphongpricha, Kanokwan K; Xie, Yuying Y; Donnelly, Christopher R CR; Luo, Xiaobo X; Heath, Blake R BR; Zhao, Xinyi X; Bellile, Emily E; Hu, Hongxiang H; Chen, Hongwei H; Polverini, Peter J PJ; Chen, Qianming Q; Young, Simon S; Carey, Thomas E TE; Nör, Jacques E JE; Ferris, Robert L RL; Wolf, Gregory T GT; Sun, Duxin D; Lei, Yu L YL
Publication Date: 2018-09-01

Variant appearance in text: CD4: Q15L
PubMed Link: 29769207
Variant Present in the following documents:
  • Main text
View BVdb publication page



Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Bartkowiak, Todd T; Singh, Shailbala S; Yang, Guojun G; Galvan, Gloria G; Haria, Dhwani D; Ai, Midan M; Allison, James P JP; Sastry, K Jagannadha KJ; Curran, Michael A MA
Publication Date: 2015-09-22

Variant appearance in text: CD4: Q15L
PubMed Link: 26351680
Variant Present in the following documents:
  • Main text
View BVdb publication page



Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection.

Vaccine
Manuri, Pallavi R PR; Nehete, Bharti B; Nehete, Pramod N PN; Reisenauer, Rose R; Wardell, Seth S; Courtney, Amy N AN; Gambhira, Ratish R; Lomada, Dakshyani D; Chopra, Ashok K AK; Sastry, K Jagannadha KJ
Publication Date: 2007-04-30

Variant appearance in text: CD4: Q15L
PubMed Link: 17291642
Variant Present in the following documents:
  • Main text
View BVdb publication page